Trials / Completed
CompletedNCT03713216
Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Cathay General Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To determine the effect and safety of NALDEBAIN versus Morphine as needed in patients after laparoscopic cholecystectomy.
Detailed description
This is an open-labeled, randomized clinical trial. Group A will receive one dose of NALDEBAIN before surgery. Group B will receive morphine as needed. Pain will be assessed for PACU, 4, 24, 48, 72 hours after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naldebain | 150 mg Nalbuphine sebacate |
| DRUG | Morphine | Morphine |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2019-10-01
- Completion
- 2020-01-01
- First posted
- 2018-10-19
- Last updated
- 2020-07-16
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03713216. Inclusion in this directory is not an endorsement.